(Q37871572)

24 August 2017

1 reference

title

Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for. (English)

1 reference

chronic renal insufficiency

24 August 2017

main subject

1 reference

1

Goce Spasovski

1 reference

24 August 2017

3

Raymond Vanholder

1 reference

24 August 2017

Alberto Ortiz

2

0 references

author name string

Meguid El Nahas

series ordinal

4

1 reference

24 August 2017

publication date

28 April 2011

1 reference

Proteomics - Clinical Applications

24 August 2017

published in

1 reference

24 August 2017

volume

5

1 reference

24 August 2017

issue

5-6

1 reference

24 August 2017

page(s)

233-240

1 reference

Chronic kidney disease in the developing world.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Renal risk scores: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Hypertension and kidney disease: a deadly connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Chronic kidney disease: the global challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Role of remission clinics in the longitudinal treatment of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Chronic kidney disease as cause of cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Rate of kidney function decline associates with mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Chronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Chronic kidney disease definition and classification: no need for a rush to judgment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Integrating albuminuria and GFR in the assessment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Essential hypertension and risk of nephropathy: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Controversies in the treatment of idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Treatment strategies and clinical trial design in ADPKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

The number, quality, and coverage of randomized controlled trials in nephrology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Everolimus in patients with autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

An introduction to biomarkers: applications to chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Does the biomarker search paradigm need re-booting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Systems biology: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Advances in urinary proteome analysis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Clinical proteomics: A need to define the field and to begin to set adequate standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Recommendations for biomarker identification and qualification in clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Urinary proteomics in diabetes and CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Discovery of protein biomarkers for renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Application of Proteomic Analysis to Renal Disease in the Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Establishment of a European Network for Urine and Kidney Proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Systems biology to battle vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Systems biology: opening new avenues in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Renoprotective effects of renin-angiotensin-system inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

Epidemiology of CKD in Europe: an uncertain scenario

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000150

21 January 2018

Identifiers

DOI

10.1002/PRCA.201000150

1 reference

24 August 2017

1 reference